定义与测量「湿疹控制」:探索特应性湿疹患者与治疗者观点的国际定性研究
结果显示湿疹控制是多维结构,涉及疾病活动、治疗管理及心理社会功能;患者/照护者测量可提供个人化频繁数据,医生测量被认为更客观,但需考虑负担与数据分析问题。
要点
- 湿疹控制是多维概念,涵盖疾病活动、治疗管理及心理社会功能。
- 患者/照护者测量可提供个人化频繁数据,医生测量更客观。
- 需权衡患者/照护者负担及数据分析与解释问题。
核心结论
- 湿疹控制是多维结构,涉及疾病活动、治疗管理及心理社会功能。
- 患者/照护者测量与医生测量各有优势,需考虑负担及数据分析问题。
研究设计与样本
- 在线焦点小组:英国、美国、荷兰、法国、瑞典和日本的患者/照护者,共8组患者(16岁以上)和8组儿童照护者,N=97。
- 焦点小组采用框架法分析,调查数据采用主题分析,整合为理论框架。
主要发现
- 湿疹控制被描述为涉及疾病活动变化、治疗与管理及心理、社会、身体功能的多维结构。
- 患者/照护者测量允许个人账户和频繁测量,医生测量被认为较不主观。
- 应考虑患者/照护者负担及分析和解释数据的问题。
关键数值与推荐
- HOME倡议推荐所有持续3个月或以上的临床试验测量「湿疹长期控制」。
临床怎么用
- 本研究为判断测量工具/方法的内容效度和可行性奠定基础,用于临床试验中评估湿疹控制。
- 在线定性研究方法为资源有限的核心结局集开发者在国际上与多方利益相关者互动提供示例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients' health and well-being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that 'long-term control of eczema' is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema. OBJECTIVES: To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term. METHODS: Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups. RESULTS: Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty-two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered. CONCLUSIONS: This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions.
引用
- Howells L, Thomas KS, Sears AV, et al. Defining and measuring 'eczema control': an international qualitative study to explore the views of those living with and treating atopic eczema. J Eur Acad Dermatol Venereol. 2019. PMID: 30720903. doi:10.1111/jdv.15475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。